VIM and neoplasm: We found that hRAT-CMs increase the expression of vimentin in a non-tumor cell line (Figure 7D), which indicates that factors present in the CMs from hRAT have the ability to revert the phenotype of non-tumor epithelial cells to a mesenchymal phenotype.